Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention Read More > October 8, 2020
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans Read More > October 8, 2020
Polypharmacology or “Pharmacological Promiscuity” In Psychedelic Research: What Are We Missing? Read More > October 6, 2020
Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review Read More > October 5, 2020
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain Read More > October 2, 2020
The emerging role of psilocybin and MDMA in the treatment of mental illness Read More > September 30, 2020
Biosynthesis, total synthesis, and biological profiles of Ergot alkaloids Read More > September 30, 2020
N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo Read More > September 28, 2020
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Read More > September 24, 2020
